Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: yes

Intensive Care Medicine

Volumn 42, Issue 5, 2016, Pages 918-920

  Bein, Thomas ^a   Briegel, Josef ^b   Annane, Djillali ^c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; EDITORIAL; GOLD STANDARD; HUMAN; HYPOXEMIA; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MORTALITY; NEUROMUSCULAR FUNCTION; NEUTROPHIL; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY HYPOXEMIA; STEROID THERAPY; HYPOXIA; RESPIRATORY DISTRESS SYNDROME, ADULT;

HUMANS; HYPOXIA; RESPIRATORY DISTRESS SYNDROME, ADULT; STEROIDS;

EID: 84958764945     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-4162-x     Document Type: Editorial

References (13)

1. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky AS, Vincent JL, Rubenfeld GD, Thompson BT, Ranieri VM (2012) The Berlin definition of ARDS. An expanded rationale, justification, and supplementary material. Intensive Care Med 38:1573–1582
2. Fujishima S (2014) Pathophysiology and biomarkers of acute respiratory distress syndrome. J Intensive Care 7:32–39
3. Kress JP (2015) Mortality is the only relevant outcome in ARDS: no. Intensive Care Med 41:144–146
4. Meduri GU, Muthiah MP, Carratu P, Eltorky M, Chrousos GP (2005) Nuclear factor-kappa B-and glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuro Immuno Modulation 12:321–338
5. Burnham EL, Janssen WJ, Riches DW, Moss M, Downey GP (2014) The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J 43:276–285
6. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE (2009) The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136:1631–1643
7. Coudroy R, Jamet A, Penuelas O, Thille AW (2015) Use of type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliterative therapy? Intensive Care Med 41:1159–1160
8. Meduri GA, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS. Chest 131:954–963
9. Bernard GR, Luce JM, Sprung C, Rinaldo JE, Tate RM, Sibbald W, Kariman K, Higgins S, Bradley R, Metz CA, Harris TR, Brigham KL (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565–1570
10. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M (2006) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
11. Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RA, Kocak M (2015) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. doi:10.1007/s00134-015-4095-4
12. Meduri GU, Tolley EA, Chrousos GP, Stentz F (2002) Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 165:983–991
13. Hough C, Steinberg KP, Thompson BT, Rubenfeld G, Hudson LD (2009) Intensive care unit-aquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med 35:63–68